Last reviewed · How we verify
Antimycobacterial regimen
Antimycobacterial regimen is a Antimicrobial Small molecule drug developed by Savara Inc.. It is currently in Phase 2 development for Treatment of pulmonary nontuberculous mycobacterial disease.
Antimycobacterial regimen works by inhibiting the growth of Mycobacterium tuberculosis.
Antimycobacterial regimen works by inhibiting the growth of Mycobacterium tuberculosis. Used for Treatment of pulmonary nontuberculous mycobacterial disease.
At a glance
| Generic name | Antimycobacterial regimen |
|---|---|
| Sponsor | Savara Inc. |
| Drug class | Antimicrobial |
| Modality | Small molecule |
| Therapeutic area | Infectious Diseases |
| Phase | Phase 2 |
Mechanism of action
The exact mechanism of action is not fully understood, but it is believed to involve the inhibition of bacterial cell wall synthesis and DNA replication. This leads to the death of the bacteria, ultimately treating the infection.
Approved indications
- Treatment of pulmonary nontuberculous mycobacterial disease
Common side effects
- Nausea
- Diarrhea
- Headache
- Fatigue
Key clinical trials
- Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis (NA)
- A Study of Doxycycline to Treat Chlamydial Infection (PHASE4)
- Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection (NA)
- PMPR and Chlorhexidine on Periodontal Disease and Vascular Function (NA)
- IO Vancomycin Spine (PHASE2, PHASE3)
- APLAUD Trial (Antibiotics vs PLacebo for Acute Uncomplicated Diverticulitis) (PHASE2)
- Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure (PHASE1)
- Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Antimycobacterial regimen CI brief — competitive landscape report
- Antimycobacterial regimen updates RSS · CI watch RSS
- Savara Inc. portfolio CI
Frequently asked questions about Antimycobacterial regimen
What is Antimycobacterial regimen?
How does Antimycobacterial regimen work?
What is Antimycobacterial regimen used for?
Who makes Antimycobacterial regimen?
What drug class is Antimycobacterial regimen in?
What development phase is Antimycobacterial regimen in?
What are the side effects of Antimycobacterial regimen?
Related
- Drug class: All Antimicrobial drugs
- Manufacturer: Savara Inc. — full pipeline
- Therapeutic area: All drugs in Infectious Diseases
- Indication: Drugs for Treatment of pulmonary nontuberculous mycobacterial disease
- Compare: Antimycobacterial regimen vs similar drugs
- Pricing: Antimycobacterial regimen cost, discount & access